Medical device recalls Moderate risk

Roche Diagnostics Operations, Inc. recalls Lactate. Intended for use on COBAS INTEGRA 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cob…

Recall date
May 7, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1926-2015
FDA classification
Class II
Brand / firm
Roche Diagnostics Operations, Inc.
Sold / distributed
US (nationwide) including PR.

Why it was recalled

Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lactate. Intended for use on COBAS INTEGRA 800 and 400 plus systems, cobas c111, Roche/Hitachi MODULAR systems, and cobas c systems for the quantitative determination of lactate concentration in plasm and cerebrospinal fluid.

Get recall alerts

Free email alert whenever Roche Diagnostics Operations, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Diagnostics Operations, Inc.